Report overview
A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO Services. This report contains market size and forecasts of Pharmaceutical CDMO Services in global, including the following market information:
Global Pharmaceutical CDMO Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pharmaceutical CDMO Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drug Substance Development and Manufacturing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CDMO Services include Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited and Piramal Pharma Solutions, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmaceutical CDMO Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical CDMO Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Type, 2022 (%)
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Global Pharmaceutical CDMO Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Application, 2022 (%)
Innovative Medicine
Patented Drug
Patent Expired Drug
Global Pharmaceutical CDMO Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CDMO Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharmaceutical CDMO Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical CDMO Services, market overview.
Chapter 2: Global Pharmaceutical CDMO Services market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical CDMO Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical CDMO Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
